CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Shares withheld for taxes Chief Accounting Officer gave up 3,087 shares (to pay taxes)
- 4 Planned sale President & COO sold 100,000 shares at $11.49 ($1,149,000)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Open-market sale Pres&Chief Investment Officer sold 412,584 shares at $12.05 ($4,971,637)
- 4 Other disposition Pres&Chief Investment Officer disposed of 3,651,985 shares (other)
- 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 958 shares (to pay taxes)
- 4 Planned sale President & COO sold 100,000 shares at $11.32 ($1,132,000)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
- 4 Grant or award Director acquired 1,231 shares (grant or award)
- 4 Grant or award Director acquired 1,613 shares (grant or award)
- 4 Grant or award Director acquired 2,303 shares (grant or award)
- 4 Open-market sale President & COO sold 100,000 shares at $11.65 ($1,165,000)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 956 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 2,340 shares (to pay taxes)
- 4 Open-market sale Director by Deputization sold 926,000 shares at an average $11.82 ($10,942,820)
- 4 Open-market sale Director sold 503,000 shares at an average $11.66 ($5,866,308)
- 4 Open-market sale Director sold 4,426,000 shares at an average $11.71 ($51,820,727)
Page 10 of 26 · 511 filings